These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18400603)

  • 1. Tamoxifen: to use or not to use.
    Yin CS
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):129-30. PubMed ID: 18400603
    [No Abstract]   [Full Text] [Related]  

  • 2. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
    Runowicz CD
    Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up of patients with early breast cancer.
    Sakemi H
    N Engl J Med; 2007 Sep; 357(10):1052-3; author reply 1053. PubMed ID: 17804856
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
    [No Abstract]   [Full Text] [Related]  

  • 5. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 6. Raloxifene (Evista) for breast cancer prevention in postmenopausal women.
    Med Lett Drugs Ther; 2006 May; 48(1234):37. PubMed ID: 16685245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen-receptor modulators for primary prevention of breast cancer.
    Fabian CJ; Kimler BF
    J Clin Oncol; 2005 Mar; 23(8):1644-55. PubMed ID: 15755972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of raloxifene on other organs without bone: uterus].
    Nozaki M
    Clin Calcium; 2004 Oct; 14(10):55-60. PubMed ID: 15577132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and the singing voice.
    Herxheimer A
    PLoS Med; 2005 Sep; 2(9):e310. PubMed ID: 16173841
    [No Abstract]   [Full Text] [Related]  

  • 10. To switch or not to switch: should the study of tamoxifen and raloxifene (STAR) trial alter our decision?
    Wang PH; Chao HT
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):372-4. PubMed ID: 18936014
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen and growth of an extrauterine leiomyoma.
    Bayya J; Minkoff H; Khulpateea N
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):90-1. PubMed ID: 18848745
    [No Abstract]   [Full Text] [Related]  

  • 12. Raloxifene: handle with care.
    Pritchard KI; Levine M; Walley B;
    CMAJ; 2001 Jul; 165(2):151, 153. PubMed ID: 11501451
    [No Abstract]   [Full Text] [Related]  

  • 13. Some antidepressants interfere with tamoxifen more than others.
    Harv Womens Health Watch; 2010 Mar; 17(7):6. PubMed ID: 20480970
    [No Abstract]   [Full Text] [Related]  

  • 14. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing perspective on breast cancer and chemotherapy. Three new developments are better able to predict breast cancer recurrence and chemotherapy effectiveness.
    Health News; 2006 Aug; 12(8):14-5. PubMed ID: 16913035
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 17. [Breast cancer chemoprevention. Rational, trials results and future].
    Cutuli B; Lesur A; Namer M; Kerbrat P
    Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemoprevention in postmenopausal women.
    Rastogi P
    Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
    Goldhaber SZ
    Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.